The Diabetes Research Center (DRC) of the University of Pennsylvania is now accepting applications for support to perform pilot & feasibility (P&F) studies in diabetes and related endocrine and metabolic disorders.

The application deadline is Monday, December 7, by 5 p.m.

The P&F program is particularly directed at new investigators and established investigators new to diabetes research. Established diabetes investigators pursuing high impact/high risk projects or projects that are a significant departure from their usual work are also eligible for support under the DRC P&F program. Applications are welcome from basic, clinical and translational investigators.

Up to two applications will be awarded for funding of metabolomics projects to be conducted by the DRC Regional Metabolomics Core at Princeton University.

Grants will be reviewed by the DRC Pilot & Feasibility Review Committee, as well as internal and external reviewers. The funding level maximum is $50,000.

For detailed information and instructions, visit http://www.med.upenn.edu/idom/derc/pilots.html

Investigators who are currently in their first year of support through this P&F program may reapply for an additional year of funding. Such continuation requests need to be carefully justified, however, and will be considered as competing renewals.

For more information please contact Lisa Henry at henryli@mail.med.upenn.edu or (215) 898-4364 or Doris Stoffers, director, DRC Pilot & Feasibility Grants Program, at stoffers@mail.med.upenn.edu or (215) 573-5413.